FTC Puts Conditions on Akorn Enterprises’ Proposed Purchase of Hi-Tech Pharmacal
Date
Akorn Enterprises, Inc. and Hi-Tech Pharmacal, Inc. will sell the rights and assets to three generic prescription eye medications and two generic topical anesthetics to Watson Laboratories, Inc., to...